Leading MDR-TB Treatment Solutions
Taj Pharma India Ltd. is a premier MDR-TB medicine manufacturer in India, specializing in the production of critical anti-tuberculosis drugs for global healthcare programs. Our expertise in manufacturing anti-tuberculosis drug formulations, particularly Bedaquiline Tablets 100mg, positions us as a key partner in the global fight against multi-drug resistant tuberculosis.
As a dedicated MDR-TB treatment drug manufacturer, we understand the critical importance of reliable supply chains, consistent quality, and regulatory compliance in TB treatment programs. Our WHO-GMP certified facilities in Mumbai, India, are equipped with specialized manufacturing processes designed specifically for anti-tuberculosis medications, ensuring optimal efficacy and safety for patients worldwide.
Anti-Tuberculosis Drug Portfolio
Bedaquiline Tablets 100mg
Primary Product- Indication: Multi-drug resistant tuberculosis (MDR-TB)
- Dosage Form: Film-coated tablets
- Strength: 100mg per tablet
- Packaging: 60, 100, 188 tablets per bottle
- Storage: Room temperature, protected from moisture
Specialized Manufacturing Expertise
Advanced Formulation
Specialized formulation development for anti-tuberculosis drugs ensuring optimal bioavailability and therapeutic efficacy
Quality Control
Rigorous testing protocols including assay, dissolution, stability studies, and microbiological testing for TB medications
Specialized Packaging
Appropriate packaging solutions ensuring product stability and compliance with international pharmaceutical standards
Regulatory Compliance
Complete regulatory documentation and compliance with international standards for anti-TB drug manufacturing
Global TB Treatment Program Support
Our role as an anti-tuberculosis drug manufacturer extends beyond production to comprehensive support for global TB treatment initiatives. We work closely with national TB programs, international health organizations, and healthcare institutions to ensure reliable access to essential MDR-TB medications.
National TB Programs
Supply partnerships with government health ministries and national TB control programs for consistent medication availability
Global Health Organizations
Collaboration with WHO, Global Fund, and other international organizations supporting TB eradication initiatives
Healthcare Institutions
Direct supply to hospitals, treatment centers, and healthcare facilities specializing in TB care
Supply Chain Solutions
End-to-end logistics support ensuring timely delivery to remote and underserved regions affected by TB
Quality & Safety Standards for MDR-TB Drugs
WHO-GMP Certification
World Health Organization Good Manufacturing Practice certification ensuring international quality standards for anti-TB medications
Stability Testing
Comprehensive stability studies under various climatic conditions ensuring product efficacy throughout shelf life
Clinical Documentation
Complete clinical and technical documentation supporting regulatory approvals and treatment guidelines
Safety Protocols
Enhanced safety measures and quality control specific to anti-tuberculosis drug manufacturing processes
Research & Development for TB Treatment
Our commitment to TB treatment extends to ongoing research and development initiatives aimed at improving anti-tuberculosis drug formulations and treatment outcomes. As a leading MDR-TB medicine manufacturer, we invest in process optimization, formulation enhancement, and manufacturing innovation to support global TB eradication goals.
Process Optimization
Continuous improvement of manufacturing processes to enhance product quality and production efficiency
Formulation Research
Research into improved drug delivery systems and formulation stability for better patient outcomes
Quality Enhancement
Development of advanced analytical methods and quality control procedures for anti-TB medications
Cost Optimization
Research initiatives aimed at reducing production costs while maintaining highest quality standards
Partner with Leading MDR-TB Medicine Manufacturer
For MDR-TB treatment program supply, institutional procurement, or partnership opportunities, contact our specialized TB medicine division. We offer comprehensive support including technical documentation, regulatory assistance, and reliable supply solutions for global TB initiatives.